Groupama Asset Management’s Edwards Lifesciences EW Stock Holding History

Groupama Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Buy	21,950 +5,260	+32%	+$441K	0.03%	155
2026 Q1	$1.34M	Buy	+16,690	New	+$1.38M	0.02%	178
2025 Q4	–	Sell	-17,203	Closed	-$1.34M	–	440
2025 Q3	$1.34M	Buy	+17,203	New	+$1.34M	0.02%	218
2025 Q2	–	Sell	-17,935	Closed	-$1.27M	–	401
2025 Q1	$1.27M	Sell	17,935 -9,874	-36%	-$707K	0.03%	230
2024 Q4	$2.06M	Sell	27,809 -6,249	-18%	-$437K	0.04%	198
2024 Q3	$1.8M	Buy	34,058 +15,319	+82%	+$1.11M	0.05%	190
2024 Q2	$1.73M	Sell	18,739 -612	-3%	-$54.2K	0.02%	226
2024 Q1	$2.64M	Sell	19,351 -10,145	-34%	-$852K	0.05%	200
2023 Q4	$2.25M	Buy	+29,496	New	+$2.05M	0.06%	192

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Groupama Asset Management's EW Position: Q2 2026 in Review

Groupama Asset Management increased its Edwards Lifesciences (EW) stake by 32% in Q2 2026, buying an estimated $441K and bringing the position to 21,950 shares worth $1.99M. The position accounts for 0.03% of the portfolio, ranked #155.

Groupama Asset Management first reported a position in EW in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.64M in Q1 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Groupama Asset Management held 21,950 shares of Edwards Lifesciences worth $1.99M as of Q2 2026.
Groupama Asset Management bought 5,260 Edwards Lifesciences shares in Q2 2026, an estimated $441K.
Edwards Lifesciences made up 0.03% of Groupama Asset Management's portfolio in Q2 2026, its #155 holding.
Groupama Asset Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 9 quarters since.
Groupama Asset Management's Edwards Lifesciences position peaked at $2.64M in Q1 2024.
1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.